|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.75 AUD | -3.37% |
|
-1.01% | -3.92% |
| Apr. 24 | Germany's Evotec Appoints Permanent CEO | MT |
| Apr. 18 | Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis | MT |
EVT Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported revenue was AUD 685.62 million compared to AUD 468.39 million a year ago. Net income was AUD 96.74 million compared to AUD 33.35 million a year ago.
Basic earnings per share from continuing operations was AUD 0.6 compared to AUD 0.207 a year ago. Diluted earnings per share from continuing operations was AUD 0.593 compared to AUD 0.205 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.92% | 1.28B | |
| +17.97% | 4.33B | |
| +25.27% | 2.14B | |
| -.--% | 1.78B | |
| -15.44% | 1.66B | |
| -10.07% | 1.34B | |
| -10.51% | 1.15B | |
| -20.74% | 1.13B | |
| -44.28% | 907M | |
| -.--% | 818M |
EVT LIMITED 
